PeptidePedia The community reference

Lot traceability: difference between revisions

Diff·revision 20 → 21·01:47, 29 May 2025

Difference between revision 20 and revision 21 of Lot traceability. 6 lines changed; the page grew by 749 bytes.

Revision 20 — 11:30, 6 May 2025
AttributeAnders (talk)
add the note on how to request a batch record rather than a certificate
4,028 bytes +26
Revision 21 — 01:47, 29 May 2025
OpenLabelOtto (talk)
add the note that self-submitted reports are a self-selected sample
4,777 bytes +749
35Consolidation is the second most consequential. Where a shipment draws several lots and the paperwork names one, every subsequent inference about the material is unsound, and this failure is invisible to the recipient.35Consolidation is the second most consequential. Where a shipment draws several lots and the paperwork names one, every subsequent inference about the material is unsound, and this failure is invisible to the recipient.
3636
+37== What good traceability looks like from the outside ==
+38A purchaser can observe only a few things, and none of them proves traceability — they are the observable consequences of it.
+39
+40The lot identifier appears on the vial, on the certificate and on the shipping paperwork, and the three agree. The certificate is lot-specific rather than a product-level document reissued for every order. A request for a certificate covering a lot bought some time ago can be met from records rather than by reissuing a current document. Where a consignment contains more than one lot, the paperwork says so.{{r|reports}}
+41
37== References ==42== References ==
38{{reflist}}43{{reflist}}
39<ref name="iso9001">ISO 9001:2015, ''Quality management systems — Requirements'', clause 8.5.2 (identification and traceability).</ref>44<ref name="iso9001">ISO 9001:2015, ''Quality management systems — Requirements'', clause 8.5.2 (identification and traceability).</ref>
40<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref>45<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref>
+46<ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref>
41<ref name="ich_q7">International Council for Harmonisation, ''Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients'' (2000).</ref>47<ref name="ich_q7">International Council for Harmonisation, ''Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients'' (2000).</ref>
4248